XML 91 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Tables)
12 Months Ended
Jun. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Nonvested Restricted Stock
 Non-Vested Restricted Stock Awards
 Number of
Shares
Weighted Average
Grant Date
Fair Value
Outstanding at July 1, 20222,305 $57.47 
Granted298 51.90 
Vested(738)60.89 
Forfeited(526)55.66 
Outstanding at June 30, 20231,339 $54.45 
Granted1,334 36.38 
Vested(476)56.04 
Forfeited(671)47.14 
Outstanding at June 28, 20241,526 $41.35 
Stock Based Compensation Expenses
The following table presents share-based compensation expenses from continuing operations included in the Company’s Consolidated Statements of Operations and Comprehensive (Loss) Income:
 Fiscal Years Ended
 June 28, 2024June 30, 2023July 1, 2022
Cost of revenues$2,919 $2,926 $2,161 
Selling, general and administrative16,936 18,335 30,116 
Research and development5,814 6,492 6,016 
Stock-based compensation expense before tax25,669 27,753 38,293 
Income taxes(6,931)(7,216)(10,339)
Stock-based compensation expense, net of income taxes$18,738 $20,537 $27,954 
Summary of Stock Option Plans
The following table summarizes activity of the Company's stock option plans since July 1, 2022:
Options Outstanding
Number of
Shares
Weighted 
Average
Grant Date
Fair Value
Weighted 
Average
Exercise Price
Weighted 
Average
Remaining
Contractual 
Term (Years)
Aggregate
Intrinsic Value as of 6/28/2024
Granted934 $12.71 $45.00 
Exercised— $— 
Cancelled— $— 
Outstanding at June 28, 2024934 $12.71 $45.00 3.69 years$— 
Exercisable at June 28, 2024— $— $— — $— 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The Company calculated the fair values of the options grants using the following weighted-average assumptions:
Fiscal Year Ended
June 28, 2024
Expected volatility45 %
Expected term4 years
Risk-free interest rate4.44 %
Expected dividend yield— %
Weighted-average grant date fair value per share$12.71